Bristol Myers is selling at 935.22 as of the 17th of January 2025; that is 6.37% down since the beginning of the trading day. The stock's last reported lowest price was 935.22. Bristol Myers has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 17th of January 2025. Click here to learn more.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. More on Bristol Myers Squibb
Bristol Myers Squibb [BMYMP] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.11 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bristol Myers Squibb classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry.
Bristol Myers Squibb has accumulated about 6.07 B in cash with 16.21 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Check Bristol Myers Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Bristol Myers without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Content Syndication Now
Content Syndication
Quickly integrate customizable finance content to your own investment portal
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.